1Rudwaleit M, Hohler T. Cytokine gene polymorphisms relevant for the spondyloarthropathies[J]. Curr Opin Rkeumatol,2001, 13(4) :250.
2Tamer IH, Miiller-Ladner U, Uhlemann C, et al. The effect of mild whol e-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis[J]. Clin Rheumatol,2009,28(4) :397 - 402.
3Toriani Terenzi C,Fagiolo E. IL-10 and the cytokine network in the pathogenesis of human autoimmune hemolytic anemia [J]. Ann N Y Acad Sci, 2005,1 051 : 29 - 44.
4Barcellini W,Clerici G, Montesano R, et al. In vitro quantification of anti red blood cell antibody production in idiopathic autoimmune haemo lyric artaemia: effect of mitogen and cytokine stimulation[J]. Br J Haernatol, 2000,111 ( 2 ) : 452 - 460.
5Barros MM, Blajchman MA, Bordin JO. Warm autoimmune hemolytic anemia: recent progress in understanding the immunobiology and the treatment[J]. Transfus Med Rev, 2010,24 ( 3 ) : 195 - 210.
6Kita T, Sakaeda T, Adachi S, et al. N-acetyltransferase 2 genotype correlates with sulfasarazine pharmacokinetics after multiple dosing in healthy Japanese subjects[J]. Biol Pharm Bull. 2001,24(10) 1176.
7Tanigawara Y, Kita T, Aoyama N, et al. N-acetyhransferase 2 genotype related sulfapyridine acetylation and its adverse[J]. Biol Pharm Bull,2002,25(8) : 1058.
8Kumagai S, Komada F, Kita T, et cd. N-aeetyhransferase 2 genotype related efficacy of sulfasalazine in patients with rheumatoid arthritis[J].Pharm Res, 2004,21(2) :324.
9Pawlik A, Ostanek L. Brzosko I, et al. Increased genotype frequency of N-acetyhransferase 2 slow acetylation in patients with rheumatoid arthritis[J]. Clin Pharmacol Ther,2002,72(3) :319.
10Nacak M, Aynacioglu AS, Filiz A, et al. Association between the N-acetylation genetic polymorphism and bronchial asthma [J]. Br J Clin Pharmacol, 2002,54 (6) : 671.
